Effects of dust scattering albedo and 2175 A bump on ultraviolet colours of normal disc galaxies

We discuss dust properties in the interstellar medium (ISM) of nearby normal galaxies, by comparing observations in the ultraviolet (UV) with simulations by a radiative transfer model. The observed UV colours of nearby galaxies show a reddening relative to their expected intrinsic colours. Some authors argued that the Milky Way dust cannot reproduce the reddening because of the prominent 2175 \AA absorption bump. Other authors proposed a reduction mechanism of the bump strength in an {\it attenuation law} derived from the ratio of the observed intensity to the intrinsic one through an age-selective attenuation (i.e., young stars are more attenuated selectively). We newly find that the wavelength dependence of the scattering albedo also has a strong effect on the UV colour; an albedo decreasing toward shorter wavelengths (except for the absorption bump range) produces a significant UV reddening. After comparing the observed UV colours of nearby normal galaxies with those expected from radiative transfer simulations assumed several dust models, we find two sorts of dust suitable for these galaxies: (1) dust with a bump and a smaller albedo for a shorter wavelength (except for the bump range), and (2) dust without any bump but with an almost constant albedo. If very small carbonaceous grains responsible for the common unidentified infrared emission band are also the bump carrier, the former dust is favorable. Finally, we derive mean attenuation laws of various dust models as a function of the UV attenuation, and derive some relations between the UV attenuation and observable/theoretical quantities.Comment: MNRAS in pres

A useful approach to total analysis of RISC-associated RNA

This is an Open Access article distributed under the terms of the Creative Commons Attribution Licens

Emergencetime and period of chironomid midges occurrlng from an indoor drainage

Mass emergence ofchironomidmidges often leads to severe nuisance conditions in food industries. We tried to clarifythe seasonal abundance and the emergence time of chironomids caught by a light traps in this industry. A total of38,708 chironomids was collected duringthe study period, andthe largest number of adult was recorded in fall. In addition, some chironomids were collected even in thewinter. These results suggest that air temperate in winter at this industry is highenough for emergence of chironomids.Asfbr emergence time,the number of chironomids increased around dawn and dusk,and decreased in the day and night. The results of the present study would be useful information for drafting planto prevent outbreaks of nuisancemidges from indoor sewage drain.Article信州大学山地水環境教育研究センター研究報告 6: 109-114(2010)departmental bulletin pape

Effects of lipid-lowering drugs on intermediate-density lipoprotein in uremic patients

Effects of lipid-lowering drugs on intermediate-density lipoprotein in uremic patientsBackgroundPatients with chronic renal failure often have alterations in lipoprotein profile including elevated very-low density lipoprotein (VLDL) and intermediate density lipoprotein (IDL), and reduced high density lipoprotein (HDL) levels. Among these changes, raised IDL has been shown as an independent risk factor for atherosclerosis in hemodialysis patients. There are a limited number of studies reporting pharmacological approaches to IDL reduction in a uremic population.MethodsWe therefore summarize the effects of lipid-lowering drugs on IDL levels in patients with chronic renal failure treated by hemodialysis (HD) or continuous ambulatory peritoneal dialysis (CAPD).ResultsFirst, a nicotinic acid analog niceritrol was given to hemodialysis patients. The drug increased HDL-cholesterol by 11%, but the reductions in VLDL-, IDL- and LDL-cholesterol were not significant. Second, CAPD patients were treated with a fibric acid derivative clinofibrate, which was excreted mainly into bile unlike other drugs in this class. The fibrate resulted in a remarkable reduction in VLDL-triglycerides, although it did not reduce IDL-cholesterol. Finally, an HMG-CoA reductase inhibitor (statin) pravastatin was used in HD and CAPD patients. Pravastatin reduced IDL- and LDL-cholesterol to the same extent (by 31%). None of these treatments caused serious adverse effects.ConclusionsWe propose that IDL is an important target in the management of uremic dyslipidemia. To date, statins have been shown to be suitable for this purpose, although it remains to be clarified whether such an intervention reduces the risk for atherosclerotic vascular events in the uremic population

Die Agrarwende in Deutschland : Anlässlich der BSE-Krise

植松健郎教授古稀・退職記念

Zeichen-Kommunikation/Interface-Kommunikation : Ist die Kommunikation eigentlich die Bedeutungs- bzw. Informationsübermittlung ?

第80回関西大学独逸文学会研究発表会における発表要旨特集ゲルマン語の歴史